Clicky

Charles River Laboratories International, Inc.(CRL) News

Date Title
Jun 3 Drug Development Inputs & Services Q1 Earnings: UFP Technologies (NASDAQ:UFPT) Simply the Best
Jun 2 Charles River Stock May Gain From Extended CHDI Research Deal on HD
Jun 2 Charles River Laboratories to Present at William Blair and Jefferies Conferences
Jun 2 1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of
May 30 Charles River Laboratories International, Inc. (CRL): A Bull Case Theory
May 28 Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
May 24 Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT
Apr 18 Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025
Apr 15 Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
Apr 15 Strength Seen in Charles River (CRL): Can Its 6.9% Jump Turn into More Strength?
Feb 24 Deciphering Charles River (CRL) International Revenue Trends
Feb 24 UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings
Feb 21 Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations
Feb 20 Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ...
Feb 20 Q4 2024 Charles River Laboratories International Inc Earnings Call
Feb 19 Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance
Feb 19 CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall
Feb 19 Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics
Feb 19 Charles River beats quarterly estimates on stable demand for drug development services
Feb 19 Charles River Laboratories (CRL) Tops Q4 Earnings and Revenue Estimates